Logo

PharmaShots Weekly Snapshots (November 15 - 19, 2021)

Share this

PharmaShots Weekly Snapshots (November 15 - 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Published: Nov 19, 2021 | Tags: Jazz, Sunosi, solriamfetol, NICE, Recommendation, Excessive Daytime Sleepiness, Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Published: Nov 19, 2021 | Tags: Antengene, Selinexor, ATG-010, NMPA, IND, Approval, P-I/II, SWATCH Study, Selinexor, ATG-010, Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Published: Nov 19, 2021 | Tags: Daiichi Sankyo, Quizartinib, P-III, QuANTUM-First Trial, FLT3-ITD Positive AML

Gilead Exercises its Options with Arcus for its Three Clinical-Stage Programs to Treat Cancers

Published: Nov 19, 2021 | Tags: Gilead, Exercises, Options, Arcus, domvanalimab, AB308, etrumadenant, quemliclustat, Cancers

Merck’s Keytruda (pembrolizumab) Receives the US FDA’s Approval as a Adjuvant Therapy for Renal Cell Carcinoma

Published: Nov 19, 2021 | Tags: Merck, Keytruda, pembrolizumab, US, FDA, Approval, Renal Cell Carcinoma

Novo Nordisk to Acquire Dicerna for ~$3.3B

Published: Nov 19, 2021 | Tags: Novo Nordisk, Acquire, Dicerna, ~$3.3B

GSK’s Nucala (mepolizumab) Receives the EC’s Approval for the Treatment of Eosinophil-Driven Diseases

Published: Nov 18, 2021 | Tags: GSK, Nucala, mepolizumab, EC, Approval, Eosinophil-Driven Diseases

AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19

Published: Nov 18, 2021 | Tags: AstraZeneca, AZD7442, P-III, PROVENT, TACKLE Trial, COVID-19

OncoOne Entered into an Agreement with GenScript ProBio for the Manufacturing of Monoclonal Antibody Therapies Targeting oxMIF

Published: Nov 18, 2021 | Tags: OncoOne, GenScript ProBio, Monoclonal Antibody, oxMIF

AstraZeneca’s Lokelma Receives Fast Track Designation for the Treatment of Chronic Haemodialysis with Hyperkalaemia

Published: Nov 18, 2021 | Tags: AstraZeneca, Lokelma, Fast Track Designation, Chronic Haemodialysis, Hyperkalaemia

Merck KGaA Collaborated with Burning Rock for Liquid-biopsy Based CDx Development

Published: Nov 18, 2021 | Tags: Merck KGaA, Burning Rock, Liquid-biopsy, CDx Development

Takeda Exercises its Option with Denali to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin

Published: Nov 18, 2021 | Tags: Takeda, Denali, DNL593, PTV:PGRN, Frontotemporal Dementia-Granulin

Merck and Ridgeback Present Results of Molnupiravir in P-III MOVe-OUT Trial for the Treatment of COVID-19 at ASTMH 2021

Published: Nov 17, 2021 | Tags: Merck, Ridgeback, Molnupiravir, P-III, MOVe-OUT Trial, COVID-19, ASTMH 2021

AbbVie’s Skyrizi (risankizumab) Receives EC’s Approval for the Treatment of Active Psoriatic Arthritis

Published: Nov 17, 2021 | Tags: AbbVie, Skyrizi, Risankizumab, EC, Approval, Active Psoriatic Arthritis

Biogen’s Vumerity (diroximel fumarate) Receives the EC’s Approval for the Treatment of Relapsing-Remitting Multiple Sclerosis

Published: Nov 17, 2021 | Tags: Biogen, Vumerity, diroximel fumarate, EC, Approval, Multiple Sclerosis

Merck Reports Results of Arpraziquante in P-III Clinical Trial for the Treatment of Schistosomiasis

Published: Nov 17, 2021 | Tags: Merck, Arpraziquante, P-III, Clinical Trial, Schistosomiasis

Viatris and Biocon Launch Semglee (insulin glargine-yfgn) and Insulin Glargine (insulin glargine-yfgn) for the Treatment of Diabetes in the US

Published: Nov 17, 2021 | Tags: Viatris, Biocon, Semglee, Insulin Glargine, insulin glargine-yfgn, Diabetes

Sotio Signs a Multiple Agreement with LegoChem Biosciences to Develop Novel Therapeutics for the Treatment of Solid Tumors

Published: Nov 17, 2021 | Tags: Sotio, LegoChem Biosciences, Novel Therapeutics, Solid Tumors

Mirum Reports Six Years Results of LIvmarli (maralixibat) for the Treatment of Alagille Syndrome

Published: Nov 16, 2021 | Tags: Mirum, LIvmarli, maralixibat, Alagille Syndrome

Celltrion’s Regdanvimab Receives the EC’s Approval for the Treatment of COVID-19

Published: Nov 16, 2021 | Tags: Celltrion, Regdanvimab, EC, Approval, COVID-19

AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

Published: Nov 16, 2021 | Tags: AstraZeneca, Moderna, AZD8601, P-IIa, EPICCURE Trial, Heart Failure, AHA 2021

Entos Entered into an Agreement with BioMarin for Gene Therapies to Treat Genetic Diseases

Published: Nov 16, 2021 | Tags: Entos, BioMarin, Gene Therapies, Genetic Diseases

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published in NEJM

Published: Nov 16, 2021 | Tags: Janssen, BMS, Milvexian, P-II, AXIOMATIC-TKR Study, TKR Surgery, AHA 2021, NEJM

Coherus and Junshi’s Toripalimab Receive the US FDA’s Orphan Drug Designation for the Treatment of Esophageal Cancer

Published: Nov 16, 2021 | Tags: Coherus, Junshi, Toripalimab, US, FDA, Orphan Drug Designation, Esophageal Cancer

AcelRx to Acquire Lowell for ~$32.5M

Published: Nov 15, 2021 | Tags: AcelRx, Acquire, Lowell, ~$32.5M

Vertex’s Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Receives CHMP’s Positive Opinion for the Treatment of Cystic Fibrosis in Children Aged 6 to 11

Published: Nov 15, 2021 | Tags: Vertex, Kaftrio, ivacaftor, tezacaftor, elexacaftor, Ivacaftor, CHMP, Cystic Fibrosis

Innovent Presented Results of IBI302 in P-Ib Clinical Trial for the Treatment of Neovascular Age-Related Macular Degeneration at AAO 2021

Published: Nov 15, 2021 | Tags: Innovent, IBI302, P-Ib, Clinical Trial, Neovascular Age-Related Macular Degeneration, AAO 2021

Regenxbio Presented Interim Results of RGX-314 in P-II AAVIATE and ALTITUDE Trials for Wet AMD and Diabetic Retinopathy at AAO 2021

Published: Nov 15, 2021 | Tags: Regenxbio, RGX-314, P-II, AAVIATE, ALTITUDE Trials, Wet AMD, Diabetic Retinopathy, AAO 2021

GSK and Vir’s Sotrovimab Meet its Primary Endpoints in P-III COMET-TAIL Trial for the Treatment of COVID-19

Published: Nov 15, 2021 | Tags: GSK, Vir, Sotrovimab, P-III, COMET-TAIL Trial, COVID-19

Amgen’s Lumykras (sotorasib) Receives CHMP’s Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Published: Nov 15, 2021 | Tags: Amgen, Lumykras, sotorasib, CHMP, KRAS G12C-Mutated, Non-Small Cell Lung Cancer

Related Post: PharmaShots Weekly Snapshots (November 08 - 12, 2021)

 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions